BHAV Acquisition Corp Units is a special purpose acquisition company (SPAC) focused on identifying and merging with high-growth enterprises primarily in the technology and healthcare sectors. Led by an experienced management team, the company seeks to capitalize on emerging market opportunities, aiming to execute transformative transactions that drive shareholder value. With a commitment to transparency and strategic partnerships, BHAV Acquisition Corp is well-positioned to deliver innovative solutions and maximize returns for its investors.
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $7.24 |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | $7.83M |
| % Insiders | 1.32% |
| % Institutions | 13.48% |
Volatility is currently expanding
PISCATAWAY, N.J., April 14, 2026 (GLOBE NEWSWIRE) -- BHAV Acquisition Corp (Nasdaq: BHAVU) (“BHAV” or the “Company”) today announced that, commencing April 16, 2026, holders of the units sold in the Company's initial public offering may elect to separately trade the Class A ordinary shares and the rights included in those units.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on BHAVU and any ticker you trade — then tracks every position and per-strategy win rate.
